Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride treat hair loss; more research needed for other options.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Vitamin D receptor is crucial for starting hair growth after birth.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

PRP treatment helps hair growth in most cases, but more research needed.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

The document concludes that both internal stem cell factors and external influences like the environment and hormones affect hair loss and aging, with potential treatments focusing on these areas.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Minoxidil helps hair regrowth in traction alopecia.

Higher BMI links to worse hair loss in Taiwanese men.